123 related articles for article (PubMed ID: 35223528)
1. Chemoresistance Transmission
Li X; Li K; Li M; Lin X; Mei Y; Huang X; Yang H
Front Oncol; 2022; 12():844648. PubMed ID: 35223528
[TBL] [Abstract][Full Text] [Related]
2. Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer.
Comandatore A; Immordino B; Balsano R; Capula M; GarajovĂ I; Ciccolini J; Giovannetti E; Morelli L
Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204377
[TBL] [Abstract][Full Text] [Related]
3. Cancer-Associated Fibroblasts Confer Gemcitabine Resistance to Pancreatic Cancer Cells through PTEN-Targeting miRNAs in Exosomes.
Richards KE; Xiao W; Hill R; On Behalf Of The Usc Pancreas Research Team
Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681792
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy.
Xiong J; Wang D; Wei A; Ke N; Wang Y; Tang J; He S; Hu W; Liu X
Oncotarget; 2017 Dec; 8(64):107500-107512. PubMed ID: 29296182
[TBL] [Abstract][Full Text] [Related]
5. GATA1 Promotes Gemcitabine Resistance in Pancreatic Cancer through Antiapoptotic Pathway.
Chang Z; Zhang Y; Liu J; Guan C; Gu X; Yang Z; Ye Q; Ding L; Liu R
J Oncol; 2019; 2019():9474273. PubMed ID: 31093285
[TBL] [Abstract][Full Text] [Related]
6. Exosome-mediated breast cancer chemoresistance via miR-155 transfer.
Santos JC; Lima NDS; Sarian LO; Matheu A; Ribeiro ML; Derchain SFM
Sci Rep; 2018 Jan; 8(1):829. PubMed ID: 29339789
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the Involvement of MMP14 in MMP2 Processing and Recruitment in Exosomes of Corneal Fibroblasts.
Han KY; Dugas-Ford J; Seiki M; Chang JH; Azar DT
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5323-9. PubMed ID: 25015352
[TBL] [Abstract][Full Text] [Related]
8. Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancreatic Cancer.
Li Z; Tao Y; Wang X; Jiang P; Li J; Peng M; Zhang X; Chen K; Liu H; Zhen P; Zhu J; Liu X; Liu X
Cell Physiol Biochem; 2018; 51(2):610-629. PubMed ID: 30458449
[TBL] [Abstract][Full Text] [Related]
9. Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.
Goad DW; Bressy C; Holbrook MC; Grdzelishvili VZ
Mol Ther Oncolytics; 2022 Mar; 24():59-76. PubMed ID: 34977342
[TBL] [Abstract][Full Text] [Related]
10. lncRNA SLC7A11-AS1 Promotes Chemoresistance by Blocking SCF
Yang Q; Li K; Huang X; Zhao C; Mei Y; Li X; Jiao L; Yang H
Mol Ther Nucleic Acids; 2020 Mar; 19():974-985. PubMed ID: 32036249
[TBL] [Abstract][Full Text] [Related]
11. USP44 suppresses pancreatic cancer progression and overcomes gemcitabine resistance by deubiquitinating FBP1.
Yang C; Zhu S; Yang H; Deng S; Fan P; Li M; Jin X
Am J Cancer Res; 2019; 9(8):1722-1733. PubMed ID: 31497353
[TBL] [Abstract][Full Text] [Related]
12. The Role of Exosomes in Pancreatic Cancer From Bench to Clinical Application: An Updated Review.
Chen K; Wang Q; Kornmann M; Tian X; Yang Y
Front Oncol; 2021; 11():644358. PubMed ID: 33718244
[TBL] [Abstract][Full Text] [Related]
13. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H
Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505
[TBL] [Abstract][Full Text] [Related]
14. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
[TBL] [Abstract][Full Text] [Related]
15. CKAP4, a DKK1 Receptor, Is a Biomarker in Exosomes Derived from Pancreatic Cancer and a Molecular Target for Therapy.
Kimura H; Yamamoto H; Harada T; Fumoto K; Osugi Y; Sada R; Maehara N; Hikita H; Mori S; Eguchi H; Ikawa M; Takehara T; Kikuchi A
Clin Cancer Res; 2019 Mar; 25(6):1936-1947. PubMed ID: 30610103
[TBL] [Abstract][Full Text] [Related]
16. Overcoming Microbiome-Acquired Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma.
Mendes I; Vale N
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38275398
[TBL] [Abstract][Full Text] [Related]
17. M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer.
Zhao Y; Zheng Y; Zhu Y; Zhang Y; Zhu H; Liu T
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575569
[TBL] [Abstract][Full Text] [Related]
18. The Role of Exosomes in Pancreatic Ductal Adenocarcinoma Progression and Their Potential as Biomarkers.
Hsu SK; Jadhao M; Liao WT; Chang WT; Lin IL; Chiu CC
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980662
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic Cancer Chemoresistance to Gemcitabine.
Amrutkar M; Gladhaug IP
Cancers (Basel); 2017 Nov; 9(11):. PubMed ID: 29144412
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer.
Zhou Y; Zhou W; Chen X; Wang Q; Li C; Chen Q; Zhang Y; Lu Y; Ding X; Jiang C
Acta Pharm Sin B; 2020 Aug; 10(8):1563-1575. PubMed ID: 32963950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
